作者：
Gady,Goldsobel [1]
;
Christoph,von Herrath [1]
;
Stephan,Schlickeiser [1]
;
Nicola,Brindle [2]
;
Frauke,Stähler [1]
;
Petra,Reinke [1]
;
Zami,Aberman [1]
;
Racheli,Ofir [3]
;
Gabriella,Dessole [4]
;
Stefano,Benvenuti [4]
;
Nuno M,Neves [5]
;
Rui L,Reis [6]
;
Guido,Moll [7]
;
Hans-Dieter,Volk [8]
作者单位：
Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT) at Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
[1]
Institute of Medical Immunology at Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
[2]
Berlin Centre for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
[3]
Pluristem Therapeutics Inc., Haifa, Israel.
[4]
Innovation Acta S.r.l., Siena, Italy.
[5]
Fondazione Telethon, Milan, Italy.
[6]
3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Guimarães, Portugal.
[7]
ICVS/3B's - PT Government Associate Laboratory, Braga, Portugal.
[8]
ICVS/3B's - PT Government Associate Laboratory, Guimarães, Portugal.
[9]
DOI
10.3389/fmed.2021.739987
PMID
34765617
发布时间
2024-04-04
换一批
换一批
